- Investing Ideas
- Chinese Pharmaceuticals & Biotech Healthy high growth potential
Chinese Pharmaceuticals & Biotech Healthy high growth potential
Results
6
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
6 companies
Dizal (Jiangsu) Pharmaceutical
Market Cap: CN¥23.0b
A commercial-stage biopharmaceutical company, discovers, develops, and commercializes therapeutics for the treatment of oncology and hematologic disorders.
688192
CN¥50.26
7D
-6.2%
1Y
-31.2%
PharmaResources (Shanghai)
Market Cap: CN¥4.4b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥26.75
7D
9.0%
1Y
-8.1%
AcrobiosystemsLtd
Market Cap: CN¥7.5b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥52.30
7D
0.2%
1Y
-5.2%
Chongqing Genrix Biopharmaceutical
Market Cap: CN¥8.3b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs in China.
688443
CN¥23.15
7D
0.8%
1Y
-32.8%
Inner Mongolia Furui Medical Science
Market Cap: CN¥12.5b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥46.92
7D
4.9%
1Y
7.2%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥6.8b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥12.86
7D
4.0%
1Y
-18.9%